This workbook provides a systematic framework to diagnose your product's structural DNA. Each section builds on the previous, moving from diagnosis to strategy.
Classify your product across 10 dimensions to identify the right growth motion
This workbook provides a systematic framework to diagnose your product's structural DNA. Each section builds on the previous, moving from diagnosis to strategy.
Capture the core facts, target market, and primary value proposition.
Diagnose whether your product DNA supports PLG, sales-led, or a hybrid motion.
Align pricing model with your product's complexity, value delivery, and user topology.
Identify the distinct user and buyer personas and their influence pathways.
Define the measurable "aha moment" and map the steps required to reach it.
Assess your product's inherent retention moat and identify structural churn risks.
Evaluate the natural expansion paths embedded in your product's usage.
Map your structural advantages and vulnerabilities against key competitors.
Visualize your product's profile across all dimensions to see imbalances.
Synthesize findings into a sequenced 90-day plan with clear ownership.
Establish the foundational facts about your product, market, and core value delivery.
Investor advice often fails because it applies portfolio pattern matching without understanding the product's structural constraints. A clear Product Profile separates current-state reality from destination ambition, making strategic conversations about growth motion, pricing, and category strategy more productive. It is the reference document that explains what your product supports and what would have to change for a new strategy to work.
This section forces alignment on the basic facts before diagnosing the more complex dimensions of your DNA. Ambition must be tied to the product's real operating conditions.
Strategic Insight: The most common investor misread is pushing for a PLG motion in a product with multi-stakeholder buyers and high complexity. Your Product Profile should make these constraints visible from the start.
Define your beachhead. A common failure mode is targeting a horizontal market without the resources to compete, or a vertical niche without sufficient total addressable market. Be specific about who you serve today and who you intend to serve next.
| Dimension | Your Answer | Example from Research |
|---|---|---|
| Primary ICP (Ideal Customer Profile) | Novu: Developers building notification systems | |
| Company Size Target | Healthcare forms platform: SMB clinics (Essential) & large healthcare systems (Platform) | |
| Primary Geo | Global (common for developer tools) | |
| Market Category You Compete In | Notification Infrastructure (Novu), Healthcare Form Automation (Healthcare forms platform) | |
| Category You Aspire to Own | Novu aims to own "Notification Infrastructure" as a recognized category. |
Products are built for different market positions. Understanding your archetype clarifies your strategic options and constraints. The archetype dictates your primary growth motion, pricing model, and competitive moat.
| Product Archetype | Primary Growth Motion | Typical Pricing Model | Key Metric Focus |
|---|---|---|---|
| Developer Tool | PLG / Open Source | Usage-Based / Seat | GitHub Stars, API Calls |
| Vertical SaaS | Sales-Led / Hybrid | Tiered Feature-Based | Win Rate, NRR |
| Horizontal Platform | Hybrid / PLG | Hybrid (Seat + Usage) | Market Share, DAU |
| Infrastructure | PLG / Sales-Assist | Usage-Based | Consumption Growth, Gross Margin |
Calculate your estimated market share within your defined niche. For Healthcare forms platform, the Product DNA recommended tracking market share with a Year 3 target of 3%. Without this baseline, you cannot measure category progress.
Diagnose whether your product's structure supports a product-led, sales-led, or hybrid acquisition model.
Product-led growth is not a tactic you layer onto any SaaS product. It is a structural capability that requires alignment between buyer, user, activation, and upgrade mechanics. The PLG Stress-Test framework assesses this fit. For example, Novu's assessment was a CONDITIONAL GO — its open-source flywheel created strong PLG acquisition, but activation complexity and monetization leaks required specific conditions to be met.
Investors frequently misread this dimension, pushing for PLG in products with multi-stakeholder buyers and high implementation complexity, which are structurally sales-led.
Strategic Insight: A bad conversation about growth motion sounds like opinion vs. opinion. A good one sounds like: "Here is the product structure, here is what it supports, and here is what would have to change for the other strategy to work."
Score your product on each factor below. Use the scoring circles to indicate fit (1 = poor fit, 5 = excellent fit).
Based on your scores, classify your dominant motion. Most products are hybrids.
Different motions produce different conversion and growth patterns. Knowing typical benchmarks helps you assess whether your performance is structural or operational.
| Motion | Key Indicator | Activation Pattern | Primary Risk | Typical Conversion Rate |
|---|---|---|---|---|
| PLG | Self-serve conversion > 5% | Minutes to "aha" | Monetization leakage | 3-7% free-to-paid |
| Sales-Led | Sales contact required for demo/POC | Weeks to implementation | High CAC, slow growth | 20-30% demo-to-close |
| Hybrid | Self-serve signup with sales outreach post-activation | Days to initial value | Misalignment between user adoption and buyer process | 10-15% trial-to-qualified lead |
If you are a hybrid motion, do not measure PLG conversion rates as your primary success metric. Instead, track qualified lead generation from self-serve users. Healthcare forms platform's DNA analysis highlighted the need for distinct win-rate targets per segment (>60% for Essential, >30% for Platform).
Align your pricing model with your product's complexity, value delivery, and user topology.
Investor pressure to "move to usage-based pricing" is another common misread. Pricing must match how value is realized and measured by the customer. For Novu, billing per workflow run aligns with usage. For Healthcare forms platform, a tiered model based on forms per month and seats matches its two-segment strategy (Essential vs. Platform).
Pricing architecture includes the unit of value, packaging, and the natural upgrade triggers that drive expansion revenue.
Strategic Insight: A pricing model that is misaligned with your product's DNA creates conversion friction and leaves expansion revenue on the table. The Novu PLG scorecard identified a conversion trigger problem: its free tier's 3-member cap was in a dead zone—too generous for small-team upgrades, too restrictive for collaboration virality.
| Pricing Model | Best For | Key Risk | Example | Complexity Score (1-5) |
|---|---|---|---|---|
| Per User / Seat | Collaboration tools, true multi-user products | Seat sharing / ghost accounts | Slack, Notion | 2 (Low) |
| Usage-Based | Infrastructure, APIs, variable-consumption products | Revenue unpredictability | Novu (per workflow run), AWS | 4 (High) |
| Tiered Feature-Based | Products with clear feature segments (SMB/Ent) | Feature cherry-picking | Healthcare forms platform (Essential vs. Platform) | 3 (Medium) |
| Hybrid (Seat + Usage) | Products with both collaboration and variable usage | Pricing complexity | GitHub (seats + actions minutes) | 5 (Very High) |
Compare your current pricing against the Product DNA recommendations for your target segments. Healthcare forms platform's analysis revealed a need for distinct win-rate targets by segment: >60% for Essential tier and >30% for Platform/Enterprise.
Use this matrix to evaluate which pricing model fits your product DNA based on key attributes.
| Product Attribute | Favors Per-Seat | Favors Usage-Based | Favors Tiered | Favors Hybrid |
|---|---|---|---|---|
| Value is tied to individual users | High | Low | Medium | Medium |
| Value scales with consumption | Low | High | Medium | High |
| Clear feature segmentation | Medium | Low | High | Medium |
| Multiple value dimensions | Medium | Medium | Medium | High |
| Low customer pricing sophistication | High | Low | Medium | Low |
Identify the distinct user and buyer personas, their influence pathways, and how they interact with your product.
Most B2B SaaS products serve multiple personas. Novu serves developers (builders), product managers (workflow designers), and CTOs/VP Engineering (buyers). Healthcare forms platform serves clinic staff (users) and practice administrators (buyers). Mapping this topology is critical for activation, pricing, and messaging.
Misalignment occurs when marketing addresses only one persona (e.g., Novu's marketing was developer-focused, missing PM and CTO content tracks).
Strategic Insight: The "Two Audience Problem" requires distinct content and activation paths. A product that serves developers and executives needs to speak both languages and guide each persona to their respective "aha moment."
| Persona | Primary Job | Buys? (Y/N) | Primary Goal with Your Product | Biggest Friction |
|---|---|---|---|---|
How do these personas interact during evaluation and purchase? A sales-led motion often has a buyer-driven top-down path. A PLG motion often has a user-driven bottom-up path. Your product's DNA determines which path is dominant.
For each persona, identify the content type and activation trigger that moves them forward. This prevents generic messaging that fails to resonate.
| Persona | Content That Resonates | Activation Trigger | Buyer Conversation |
|---|---|---|---|
| Developer | API docs, quickstart guides, GitHub repos | First successful API call | "Does it work?" |
| Product Manager | Case studies, workflow templates, ROI calculators | Built first workflow | "Does it save time?" |
| Executive Buyer | Security whitepapers, compliance docs, pricing tiers | Team adoption & usage data | "Is it secure and scalable?" |
Your Persona |
Define the measurable "aha moment" and map the steps required for a user to reach it.
Activation is the bridge between acquisition and retention. The Activation Review Playbook outlines eight dimensions to audit: First-Touch, Value Promise, Activation Architecture, Progressive Disclosure, Empty States, Guidance Mechanics, Social Proof, and Friction Log. A leak in any dimension increases early churn.
Novu's activation requires a developer to complete a 6-step process with external provider dependencies—a high-friction pattern that limits conversion.
Strategic Insight: Most SaaS companies lack both a real onboarding flow and a churn prevention system. These are the two bookends of the customer lifecycle. Building your first iteration of both is a priority.
Map the steps from signup to the aha moment. Use the checklist to identify friction points.
| Step # | User Action | Friction Score (1-5) | Drop-off % (Est.) |
|---|---|---|---|
| 1 | Sign up / form fields |
____% |
|
| 2 | First screen / empty state |
____% |
|
| 3 | First key action (e.g., create project) |
____% |
|
| 4 | Achieve aha moment |
____% |
Compare your activation expectations against industry benchmarks for your product archetype. This highlights whether your friction is typical or excessive.
| Product Archetype | Typical Time-to-Aha | Typical Activation Rate | High-Friction Indicators |
|---|---|---|---|
| Developer Tools | 5-30 minutes | 15-25% | External dependencies, complex setup |
| Vertical SaaS | 1-7 days | 10-20% | Data import, configuration, training |
| Horizontal Platforms | 1-24 hours | 20-30% | Overwhelming UI, unclear first action |
| Infrastructure | Minutes | 25-40% | Credit card requirement, no free tier |
Novu's priority action was to build a 5-email behavioral sequence inside its own platform. This fixes onboarding weakness and signals dogfooding credibility. Your sequence should guide users through the funnel steps above.
Assess your product's inherent retention moat and identify structural churn risks.
The SaaS Churn Diagnosis Playbook identifies 7 churn archetypes. The critical question is whether churn is fixable (e.g., poor onboarding) or structural (the product does not deliver enough sustained value for a customer profile). Structural churn points to a product-market fit problem that cannot be solved by customer success alone.
Your product's Retention Moat Type—whether it's built on habit, network effects, data asset, or workflow integration—determines its natural retention strength.
Strategic Insight: If your primary churn archetype is Value Gap or Product-Market Fit Failure, the diagnosis points upstream to the product itself. The fix is not better CS—it's a different hook, ICP, or pricing structure.
| Moat Type | Typical NRR | Churn Risk | Strengthening Action |
|---|---|---|---|
| Habit / Daily Use | >120% | Low | Increase daily active usage |
| Network Effects | >130% | Very Low | Drive multi-user adoption |
| Data Asset | 110-120% | Medium | Enhance data export friction |
| Workflow Integration | 105-115% | High if workflow changes | Deepen integration points |
| Weak / None | <100% | Very High | Build a moat or accept high churn |
Identify which of the seven churn archetypes is most prevalent in your customer base. This directs the appropriate intervention.
| Churn Archetype | Primary Cause | Fix Type | Example |
|---|---|---|---|
| Value Gap | Product doesn't deliver promised value | Product / Positioning | Feature missing vs. marketing claim |
| Poor Onboarding | User never reaches aha moment | Activation / Education | Complex setup, no guidance |
| Price Sensitivity | Cost exceeds perceived value | Pricing / Packaging | Upgrade too expensive, no mid-tier |
| Competitor Switch | Better alternative available | Product / Differentiation | Competitor launches superior feature |
| Usage Decline | Product not used regularly | Engagement / Habit-building | Low DAU, no recurring need |
Evaluate the natural expansion paths embedded in your product's usage and packaging.
Net Revenue Retention (NRR) is a function of churn reduction and expansion. Expansion can come from seat growth, usage overages, feature upgrades, or cross-selling add-ons. Your product's DNA dictates which paths are most natural and profitable.
Healthcare forms platform's DNA recommended an NRR target of >110%, but its analytics showed NRR was not calculated—a critical gap. Novu's expansion is driven by workflow run overages beyond the 10K free limit.
Strategic Insight: Investor pressure for high NRR can be misaligned if the product lacks a built-in expansion model. You cannot optimize for NRR without the underlying expansion architecture.
| Expansion Type | Requires | Typical Lift | Example | Implementation Complexity |
|---|---|---|---|---|
| Usage-Based | Clear metering & overage pricing | 10-30% ARR expansion | Novu workflow runs | High |
| Seat-Based | Multi-user collaboration features | 15-40% ARR expansion | Slack, Figma | Medium |
| Feature Upgrade | Clear tier differentiation | 20-50% ARR expansion | Healthcare forms platform Essential → Platform | Medium |
| Cross-Sell | Modular product portfolio | 5-15% ARR expansion | HubSpot Marketing → Sales | High |
Identify the specific events or thresholds that naturally trigger expansion. Without clear triggers, expansion is opportunistic and unpredictable.
| Trigger Type | Current Threshold | Upgrade Path | Conversion Rate (Est.) |
|---|---|---|---|
| Usage Limit | e.g., 10K workflow runs |
Free → Paid Tier |
____% |
| Seat Limit | e.g., 5 team members |
Team → Business Plan |
____% |
| Feature Need | e.g., require advanced analytics |
Essential → Platform |
____% |
| External Event | e.g., company growth, new regulation |
Add-on or higher tier |
____% |
Map your structural advantages and vulnerabilities against 2-3 key competitors.
Competition is not just about features. It's about whose product DNA is better matched to the market's evolution. Novu's open-source community (38.7K GitHub stars) is a structural moat most competitors cannot replicate. Healthcare forms platform's deep vertical integration in healthcare is a moat against horizontal form builders.
Investors often misread moat type, expecting network effects in a tool-centric product. Your job is to articulate your real moat.
Strategic Insight: Category creation, like Novu's push for "notification infrastructure," is won with content that teaches the market to recognize a problem they already have, in terms they didn't have before.
| Dimension | Us | Competitor A: ________ | Competitor B: ________ |
|---|---|---|---|
| Growth Motion | |||
| Pricing Model | |||
| Primary Moat | |||
| Activation Speed | |||
| Top Vulnerability |
Plot your competitors on a matrix of key strategic dimensions to visualize relative strengths and weaknesses.
| Competitor | Market Share | Growth Rate | NRR | Primary Attack Vector |
|---|---|---|---|---|
| Your Product | ____% | ____% YoY | ____% | |
| Competitor A | ____% | ____% YoY | ____% | |
| Competitor B | ____% | ____% YoY | ____% | |
| Competitor C | ____% | ____% YoY | ____% |
Novu's strategy included stack-specific quickstart guides (Next.js, Rails, etc.) that served acquisition, activation, and SEO simultaneously. Create content that defines the category on your terms.
Visualize your product's profile across all dimensions to identify imbalances and strategic priorities.
A radar chart makes imbalances visible. A product with a strong PLG score but weak retention moat is acquisition-rich but retention-poor. A product with strong pricing but poor activation will struggle to convert. Plot your scores from the previous sections to see your product's true shape.
This visualization helps align the team and board on where to focus investment. It turns abstract DNA into a concrete strategic asset.
Strategic Insight: The radar chart is the synthesis tool that prevents local optimization. It answers the question: "Are we strong where we need to be strong, given our chosen strategy?"
Rate each dimension on a scale of 1 (weak/underdeveloped) to 5 (strong/optimal). Use your work from previous sections.
Based on your scores, prioritize which dimensions to improve first. Consider both impact on growth and feasibility of improvement.
| Dimension | Current Score | Impact on Growth | Feasibility (1-5) | Priority (H/M/L) |
|---|---|---|---|---|
| Market Fit Clarity | 1 | Critical | 3 | H |
| Activation Path Design | 5 | High | 5 | L |
| Retention Architecture | 3 | High | 4 | H |
| Expansion Revenue Model | 2 | Critical | 3 | H |
| Pricing Architecture | 3 | High | 4 | M |
| Competitive Moat | 4 | Medium | 3 | M |
| Buyer & User Influence | 2 | High | 4 | H |
| Analytics Alignment | 1 | Critical | 5 | H |
| Operational Execution | 3 | Medium | 4 | M |
ProductQuant Workbook